# A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

Study · id `cardio:ct-nct06168942` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06168942](<https://clinicaltrials.gov/study/NCT06168942>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06168942

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT06168942. Randomized; no masking; primary purpose treatment. Start 2024-02-19 (actual); primary completion 2028-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT06168942, source copy `cardio:ctgov-nct06168942-2026-10-19`, retrieved 2026-10-26)
- Started: 2024-02-19 (actual) (ClinicalTrials.gov record NCT06168942, source copy `cardio:ctgov-nct06168942-2026-10-19`, retrieved 2026-10-26)
- Primary completion: 2028-12-01 (anticipated) (ClinicalTrials.gov record NCT06168942, source copy `cardio:ctgov-nct06168942-2026-10-19`, retrieved 2026-10-26)
- Completion: 2032-02-29 (anticipated) (ClinicalTrials.gov record NCT06168942, source copy `cardio:ctgov-nct06168942-2026-10-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06168942, source copy `cardio:ctgov-nct06168942-2026-10-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06168942-2026-10-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
- Condition: Non-valvular Atrial Fibrillation
- Condition: Stroke
- Condition: Systemic Embolism
- Intervention (Device): Experimental: Laminar Left Atrial Appendage Closure System
- Intervention (Device): Active Comparator: WATCHMAN / Amulet
- Lead sponsor: Jaguar LAA, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 3bf54641a17d18ff69e4993329715e63c374c7e52e01dc3bc44db35b8dd15288
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
